疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

Vaccines, 6th Edition

' Y  `$ {6 _- n8 F  T& W$ ~& m5 L- EApply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

! ^( U; G% w- h/ |6 fhttp://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

* r- ?3 F. f6 k0 @% G0 LSECTION 1: General aspects of vaccination
% S' U! }8 ?% H2 a# c1 A short history of vaccination 1
2 Vaccine immunology 14
3 The vaccine industry 33
4 I7 B2 c3 c. o4 Vaccine manufacturing 44
8 J% p: {; {8 |& i( x. E% L5 Evolution of adjuvants across the centuries 58
9 j' s: ~4 H* s6 _6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
- F8 Q% k; y8 D6 N7 Passive immunization 80
6 G6 z7 G; A6 e5 G2 X8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
! A- O* B% [; F& [( |: J. F: c9 s10 Anthrax vaccines 127
3 @7 a, D* b  x% k7 H+ U" I  Q11 Cholera vaccines 141
$ a1 M& N6 n/ s! n7 W" F12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
( ~# w$ C! Y$ a  i5 a14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
' m) Z, ]* f# H, a3 I7 b18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
, c/ s! O! S+ l$ `3 r+ S% j7 ?0 H( ~20 Measles vaccines 352
: o; Q" H! r' ~21 Meningococcal vaccines 388
; n1 j( E* n& h  i" E$ \/ }22 Mumps vaccine 419
23 Pertussis vaccines . 447
24 Plague vaccines 493
/ H& t/ n* b6 Y. ?+ w25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
) O% S& Y3 M+ \, ~" L: G2 |26 Pneumococcal polysaccharide vaccines 542
27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
' X6 K* J( @" ]6 M29 Rabies vaccines .646
30 Rotavirus vaccines . 669
& Y! E2 T+ N8 V, D" }; A% V& T31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
2 d: N* K7 C+ \7 j) j  w36 Typhoid fever vaccines 812
6 l' ?, \0 o# b. P' g$ a4 i37 Varicella vaccine 837
38 Yellow fever vaccine 870
0 z& y% z; A7 H0 n  J% h6 G' Y; E39 Zoster vaccine 969
. w( K% V/ z6 h" T40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
! H2 k7 f% h' h2 C+ C41 Biodefense and special pathogen vaccines 1008
42 Therapeutic cancer vaccines 1018
0 U, O1 e0 d% P0 _3 p6 `7 D43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
' l  v& u; s6 T# H' M+ @7 y45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
2 ^* C, x9 i. B, E) ^) f  y5 E48 Hepatitis C vaccines 1074
& _* e+ G5 N/ j% O: x7 b49 Hepatitis E vaccines 1085
% }' x% l3 O6 p$ l" ^50 Herpes simplex virus vaccines 1090
0 H) X! m( ?0 p51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
/ |9 n7 I4 a6 x% P& ]: _- J+ e54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
59 Streptococcus group B vaccines 1176
6 O/ Q; j- c1 z5 B1 p' O+ n60 Technologies for making new vaccines 1182
  P( Z, D$ T8 E7 F1 ^# u$ h: s+ k3 F61 Alternative vaccine delivery methods 1200
* s6 y% G1 H0 C62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
1 K$ s6 m) y( A& b3 l( x, P  _8 l63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
" |9 D3 S' Y# T5 ?9 X! ~: ^  n65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
: c" R% W+ j2 d4 ~* Q. [* CSECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
  g& `! F! m9 Y7 [68 Immunization in Europe . 1334
' {- `& I2 E: i# A69 Immunization in the Asia-Pacific region 1353
3 l; v' j- N0 {+ d1 L6 O/ p& c0 \70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
% w) o" U. U3 n8 f4 `, v! S  ^2 H75 Regulation of vaccines in developing countries 1454
76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508
5 i1 R6 r! ], K/ J3 t8 J: G

2 c+ Z9 t3 b/ f" P) b
& H3 N7 |- [" }, E6 Q4 {; K# S3 C

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
! c) Y7 h( P5 o! }: D( ^& o
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

/ F/ N' i' l5 @6 rhttp://yun.baidu.com/share/link? ... 1&uk=3810996606
' T. _" ^  O# ]) i
SECTION 1: General aspects of vaccination
5 C9 L  M2 `& {( X1 A short history of vaccination 1
; T6 E) I6 i& n. p# X: O8 X3 {( B2 Vaccine immunology 14
: }: K3 s. m8 m% b3 The vaccine industry 33
  ?; u% N, y, E9 f5 P4 Vaccine manufacturing 44
! r' \6 \) K% x) _, X5 Evolution of adjuvants across the centuries 58
, O, [( E4 s4 E6 Vaccine additives and manufacturing residuals in the United States:
+ v( A* s" Z; A  B( j: \- mlicensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
" N. O, @* d' w! F8 v9 Adenovirus vaccines 113
% \! _, j% K& O7 b10 Anthrax vaccines 127
11 Cholera vaccines 141
12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
% Y. m6 o0 ?, V* p/ T  d  f14 Hepatitis A vaccines 183
. Q- i0 f! a. C+ D/ f  x! x15 Hepatitis B vaccines 205
+ L- Y" {& X! G0 O3 @9 o16 Human papillomavirus vaccines 235
0 t' ^( x0 h% O4 \( c17 Inactivated influenza vaccines 257
4 P, [+ _! c6 g18 Influenza vaccine-live 294
6 F2 }: g2 v5 w, r; J' y19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
21 Meningococcal vaccines 388
4 h6 ~8 z$ o5 y& s* \  Z! B22 Mumps vaccine 419
23 Pertussis vaccines . 447
2 O! e7 n8 ?4 u, z24 Plague vaccines 493
5 X# C% q4 k1 ^4 y25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
  W' d$ Z" S/ d! i& M6 o: a26 Pneumococcal polysaccharide vaccines 542
; b( g' d4 G$ _; G1 q, s; m. K8 a- w27 Poliovirus vaccine-inactivated . 573
1 D; `/ g, t, I, X28 Poliovirus vaccine-live 598
  k/ ^; ]# z$ Y  n29 Rabies vaccines .646
0 N  T4 m/ Z5 ~30 Rotavirus vaccines . 669
' M3 e2 ^2 i! j, E, a, [& a31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
37 Varicella vaccine 837
+ h- j9 o0 d, Q5 g& @38 Yellow fever vaccine 870
+ h' B% m$ o3 I( M! p6 M39 Zoster vaccine 969
! q7 g& Q2 y5 g9 p, Q2 {8 s- T, B+ h$ M& F40 Combination vaccines 981
* d! X! k* P/ y5 ?2 cSECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
5 f; b9 i& ]4 }42 Therapeutic cancer vaccines 1018
1 x& @% Q1 V4 z; t# n2 @43 Cytomegalovirus vaccines 1032
) S0 }8 |( Z3 ~44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
, h% P& ?6 M; y46 Ebola vaccine 1060
& C% C$ p! f* _9 K) ?4 [4 v47 Epstein-Barr virus vaccines 1068
2 s$ J+ K* J5 W9 U- M5 b3 @48 Hepatitis C vaccines 1074
" U  X8 S* Z, K. A/ P49 Hepatitis E vaccines 1085
0 v5 o* j5 ~* j50 Herpes simplex virus vaccines 1090
% I! F' @* [! E; Y6 R; J51 Human immunodeficiency virus vaccines 1097
" ?; B1 V/ \0 I, w; H/ |52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
54 Noninfectious disease vaccines 1138
/ d# n: p0 a) @1 j55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
% J( \" b# V5 D$ n56 Parasitic disease vaccines 1154
2 _+ _1 \$ h  x* A57 Staphylococcus aureus vaccines 1161
9 X6 I5 c6 C. \, s. M% ~" f' N4 F58 Streptococcus group A vaccines 1169
6 Y" o8 t7 E5 o' d6 n4 F59 Streptococcus group B vaccines 1176
6 b( g; @. {9 v- e* ^9 V$ {60 Technologies for making new vaccines 1182
  h+ E" }9 W0 [61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
4 v  `1 l4 J3 u8 cSECTION 4: Vaccination of special groups
5 n5 R/ H5 |9 M" N" n" p7 k63 Vaccination of immunocompromised hosts 1243
- e! p* g4 u! V$ Q! Y" I3 s- D' p( t% z64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
, y/ K3 V5 o4 s66 Vaccines for health care personnel 1290
& X) Y) {: `" F% P! X7 t/ MSECTION 5: Public health and regulatory issues
, P: Z+ F, P% {; q7 z67 Immunization in the United States 1310
/ X: b* n, u, z7 ]  w68 Immunization in Europe . 1334
2 R" N4 U( G% z& }1 }% C* a69 Immunization in the Asia-Pacific region 1353
, U7 |8 Y& L: R7 A! K$ u70 Immunization in developing countries 1369
71 Community immunity 1395
72 Economic analyses of vaccine policies 1413
' K6 E: D; y/ c. R7 p# L73 Regulation and testing of vaccines 1427
4 P2 ~" I7 U8 j! _: T( D7 c6 S8 ~" g74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
# z! Y2 O& n& Z7 Z/ H76 Vaccine safety 1464
77 Legal issues . 1481
% C- u" X' v: [  L78 Ethics 1508

8 k2 Y. ?, o9 b6 ~( s- k+ t

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
7 Z+ k1 x& e2 o. Z0 L, xPublisher: Saunders; 6 edition (October 30, 2012)
Language: English
ISBN-10: 1455700908
Size: 52.3mb (original pdf)

2013 BMA Medical Book Awards Highly Commended in Public Health!
, }8 \  B4 z+ O  G. }: _5 _Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

Gain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
Update your knowledge of both existing vaccines and vaccines currently in the research and development stage.
Get complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
/ k# k( h6 f1 n8 q% i! A; t; v( |Analyze the cost-benefit and cost-effectiveness of different vaccine options.
; m/ k4 Z$ w/ K4 f- IClearly visualize concepts and objective data through an abundance of tables and figures.
% S3 Z! v$ D: o3 J, w5 e! qPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
' x# q5 ]9 H, y" `4 lMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.
9 x: A+ ?9 l" T" f2 |2 Z
1 q3 S2 j0 q0 F! CDownload link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96